Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 4, 2005

View Archived Issues

Second interim analysis of phenserine tartrate study in Alzheimer's disease

CholeraGarde reported safe and immunogenic in children and infants

A phase III study confirms the efficacy of telbivudine in compensated chronic hepatitis B

Posiphen given green light to begin phase I

Human Genome Sciences receives milestone payment for GSK-716155

Antiinflammatory compound QR-440 shows disease-modifying potential

BioMarin submits Orapred ODT NDA

Fast track designation for panitumumab for metastatic colorectal cancer

MN-166 enters phase II study for relapsing-remitting MS

Solvay and Berna Biotech sign Aerugen license agreement

Novel compounds inhibit D816 Kit mutation tumor growth

UK-290795: an NK2 antagonist with greater oral absorption

RO-4383596 demonstrates antiangiogenic and antitumor effects

Oracea NDA filed

Peplin raises funds for leukemia program of PEP-005 IV

Kyorin and LG Life Sciences sign memorandum of understanding for KRP-197

Provisional patent application on novel anticancer compounds

Novel analgesic agents claimed in recent patent literature

Therapeutic benefits found for XP-13512 in RLS

Ghrelin increases acute energy intake in malnourished peritoneal dialysis patients

Positive benefits of coenzyme Q10 in Parkinson's disease

Synergistic effects reported for tipifarnib plus taxanes in multiple myeloma

New targets and treatments reported for psychosis, depression, etc.

iNOS inhibitors prepared and tested by Altana Pharma

Antiplatelet effects reported for S-18886 in patients with peripheral artery disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...